假结核棒状杆菌(C.P),兼性细胞内细菌,是一种重要的人畜共患病原体,可引起脓肿和化脓性肉芽肿。肠道菌群与宿主健康或疾病之间的关系越来越受到关注。然而,肠道菌群在C.p感染过程中的作用尚不清楚。在这项研究中,我们在C57BL/6小鼠中建立了C.p感染模型,并检查了先发制人口服嗜酸乳杆菌(L.嗜酸菌)感染。我们的发现揭示了C.p感染导致肝脏和肾脏明显的病理改变,以脓肿形成为特征,强烈的炎症反应,和细菌过载。值得注意的是,这些有害作用通过在感染C.p.之前口服嗜酸乳杆菌大大缓解。我们进一步发现,在C.P感染期间,口服嗜酸乳杆菌的小鼠的腹膜巨噬细胞(PM)在感染部位积累得更快。此外,我们的结果表明,口服嗜酸乳杆菌的小鼠的PMs表现出更强的C.P清除作用,这是由LC3-II蛋白的高表达介导的。同时,口服嗜酸乳杆菌保护了由C.p感染引起的C57BL/6小鼠的肠道微生物群紊乱。总之,我们的研究表明,口服嗜酸乳杆菌通过调节巨噬细胞自噬赋予C57BL/6小鼠对C.p感染的有效保护,从而增加细菌清除并保持肠道微生物群和功能稳定性。这些发现将嗜酸乳杆菌定位为临床预防C.p感染的可行益生菌候选物。
目标:假结核棒状杆菌(C.p)已知会在动物和人类中诱发一系列慢性疾病。目前,C.p感染的临床治疗主要依靠抗生素治疗或手术干预。然而,过度使用抗生素可能会增加耐药菌株的风险,治疗效果仍不能令人满意。此外,外科手术不能完全根除病原体,很容易造成环境污染。益生菌干预在改善人体免疫系统和保持健康方面正受到越来越多的关注。在这项研究中,通过建立C57BL/6小鼠C.p感染模型,探讨嗜酸乳杆菌对C.p感染的影响。我们的结果表明,嗜酸乳杆菌通过调节巨噬细胞的自噬和维持肠道菌群稳态,有效地保护了C.p感染。本研究可能为C.p感染的预防提供新的策略。
Corynebacterium pseudotuberculosis (C. p), a facultative intracellular bacterium, is an important zoonotic pathogen that causes abscesses and pyogenic granulomas. The relationship between gut microbiota and host health or diseases has received increasing attention. However, the role of gut microbiota in the process of C. p infection is still unclear. In this study, we established a C. p infection model in C57BL/6 mice and examined the impact of preemptive oral administration Lactobacillus acidophilus (L. acidophilus) on infection. Our findings revealed that C. p infection led to pronounced pathological alterations in the liver and kidneys, characterized by abscess formation, intense inflammatory responses, and bacterial overload. Remarkably, these deleterious effects were greatly relieved by oral administration of L. acidophilus before infection with C. p. Additionally, we further found that during C. p infection, peritoneal macrophages (PMs) of mice orally administered with L. acidophilus accumulated more rapidly at sites of infection. Furthermore, our results showed that PMs from mice with oral L. acidophilus administration showed a stronger C. p
clearance effect, and this was mediated by high expression of LC3-II protein. Meanwhile, oral administration of L. acidophilus protected the gut microbiota disorder in C57BL/6 mice caused by C. p infection. In summary, our study demonstrates that oral administration of L. acidophilus confers effective protection against C. p infection in C57BL/6 mice by modulating macrophage autophagy, thereby augmenting bacterial
clearance and preserving gut microbiota and function stability. These findings position L. acidophilus as a viable probiotic candidate for the clinical prevention of C. p infection.
OBJECTIVE: Corynebacterium pseudotuberculosis (C. p) is known to induce a range of chronic diseases in both animals and humans. Currently, clinical treatment for C. p infection mainly relies on antibiotic therapy or surgical intervention. However, excessive use of antibiotics may increase the risk of drug-resistant strains, and the effectiveness of treatment remains unsatisfactory. Furthermore, surgical procedures do not completely eradicate pathogens and can easily cause environmental pollution. Probiotic interventions are receiving increasing attention for improving the body\'s immune system and maintaining health. In this study, we established a C. p infection model in C57BL/6 mice to explore the impact of Lactobacillus acidophilus during C. p infection. Our results showed that L. acidophilus effectively protected against C. p infection by regulating the autophagy of macrophages and maintaining intestinal microbiota homeostasis. This study may provide a new strategy for the prevention of C. p infection.